Brief: Oncternal Reports Third Quarter 2021 Financial Results

Oncternal Therapeutics

04/11/2021 22:15

Nov 4 (Reuters) - Oncternal Therapeutics Inc  ONCT.O :
    * ONCTERNAL PROVIDES BUSINESS UPDATE AND ANNOUNCES THIRD
QUARTER
2021 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.19
    * AS OF SEPTEMBER 30, 2021, WE HAD $97.4 MILLION IN CASH AND
CASH
EQUIVALENTS
    * BELIEVE CASH, CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND
OUR
OPERATIONS INTO 2023

Source text for Eikon:  ID:nGNXbHdMxz 
Further company coverage:  ONCT.O 

 ((Reuters.Briefs@thomsonreuters.com;))